Andere Sprachen Cellebrite DI Ltd.

Aktien

A3D00S

IL0011794802

CLBT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:01 02.05.2024			% 5 Tage	% 1. Jan.
10,85 ^USD	+0,93 %		+1,31 %	+25,29 %

19.04.	CELLEBRITE DI LTD. : Lake Street behält die Bewertung Kaufen bei	ZM
01.04.	CELLEBRITE DI LTD. : BofA Securities behält seine Kaufempfehlung bei	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024	10.04.
Cellebrite révolutionne la collecte de données avec une solution SaaS révolutionnaire faisant partie intégrante de la plateforme Case-to-Closure de l’entreprise	26.03.
Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership	25.03.
Cellebrite DI Ltd. Announces the Appointment of David Gee as Chief Marketing Officer	25.03.
Cellebrite Files its 2023 Annual Report on Form 20-F	21.03.
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform	14.03.
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform	14.03.
Cellebrite DI Ltd. Unveils Cellebrite Endpoint Inspector SaaS	14.03.
Cellebrite DI Shares Rise After William Blair Upgrades Stock to Outperform From Market Perform	13.03.
UPDATE – Cellebrite Announces 2024 Investor Day	12.03.
UPDATE – Cellebrite Announces 2024 Investor Day	12.03.
Cellebrite Launches FedRAMP Authorization Process for SaaS Offerings	07.03.
Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security	07.03.
Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security	07.03.
Cellebrite Di Ltd Announces Retainment of Haim Shani as Director	06.03.
Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase	06.03.
Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase	06.03.
Cellebrite Sees Improved Business Momentum in 2024, BofA Securities Says	16.02.
Cellebrite DI's Q4 Adjusted Earnings, Revenue Gain; Sets Revenue Outlook for Q1, 2024	15.02.
Cellebrite DI Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cellebrite DI Ltd.

Aktien

A3D00S

IL0011794802

CLBT

Andere Sprachen

Filter